Amarin highlights VASCEPA’s role amid new triglyceride therapies
Post Content
Business & Finance
Stay informed with expert takes on business strategy, investing, entrepreneurship, and global markets. CurioAtlas brings you articles that guide smarter decisions in finance and business growth.
Immunocore outlines 2026 strategy at J.P. Morgan conference
Post Content
iBio secures $26 million in private placement financing
Post Content
Athira Pharma rebrands as LeonaBio amid strategic pivot to cancer therapy
Post Content
FDA identifies deficiencies in Aquestive’s Anaphylm application
Post Content
Polestar reports 34% growth in 2025 retail sales to 60,119 cars
Post Content
MapLight Therapeutics accelerates timeline for Phase 2 trial results
Post Content
Fresenius Medical Care accelerates second tranche of share buyback
Post Content
Choppy quarter to come but stocks will take off afterwards, says this strategist
Darius Dale thinks there are at least two more rate cuts to come from the Fed but he’s worried about bonds owing to the government’s unsustainable deficit.
RBC cuts Sartorius to “sector perform on rally, cautious outlook
Post Content